These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 10209513)
1. An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model. Williamson ED; Vesey PM; Gillhespy KJ; Eley SM; Green M; Titball RW Clin Exp Immunol; 1999 Apr; 116(1):107-14. PubMed ID: 10209513 [TBL] [Abstract][Full Text] [Related]
2. Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1+rV270. Qi Z; Zhou L; Zhang Q; Ren L; Dai R; Wu B; Wang T; Zhu Z; Yang Y; Cui B; Wang Z; Wang H; Qiu Y; Guo Z; Yang R; Wang X Vaccine; 2010 Feb; 28(6):1655-60. PubMed ID: 20079562 [TBL] [Abstract][Full Text] [Related]
3. A comparison of immunogenicity and protective immunity against experimental plague by intranasal and/or combined with oral immunization of mice with attenuated Salmonella serovar Typhimurium expressing secreted Yersinia pestis F1 and V antigen. Liu WT; Hsu HL; Liang CC; Chuang CC; Lin HC; Liu YT FEMS Immunol Med Microbiol; 2007 Oct; 51(1):58-69. PubMed ID: 17640293 [TBL] [Abstract][Full Text] [Related]
4. Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague. Leary SE; Griffin KF; Garmory HS; Williamson ED; Titball RW Microb Pathog; 1997 Sep; 23(3):167-79. PubMed ID: 9281474 [TBL] [Abstract][Full Text] [Related]
5. [Evaluation of immunization protection efficacy of plague subunit vaccine]. Zhang QW; Qi ZZ; Xin YQ; Yang YH; Wu HL; Yang HQ; Feng JP; Jin X; Cui BZ; Wang T; Wu BC; Qiu YF; Wang W; Guo ZB; Wang ZY; Yang RF; Wang H; Wang XY Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Sep; 43(9):785-8. PubMed ID: 20137561 [TBL] [Abstract][Full Text] [Related]
6. A single dose sub-unit vaccine protects against pneumonic plague. Williamson ED; Eley SM; Stagg AJ; Green M; Russell P; Titball RW Vaccine; 2000 Oct; 19(4-5):566-71. PubMed ID: 11027822 [TBL] [Abstract][Full Text] [Related]
7. Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine. Demeure CE; Derbise A; Guillas C; Gerke C; Cauchemez S; Carniel E; Pizarro-Cerdá J Vaccine; 2019 Jan; 37(1):123-129. PubMed ID: 30467064 [TBL] [Abstract][Full Text] [Related]
8. Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts. Arlen PA; Singleton M; Adamovicz JJ; Ding Y; Davoodi-Semiromi A; Daniell H Infect Immun; 2008 Aug; 76(8):3640-50. PubMed ID: 18505806 [TBL] [Abstract][Full Text] [Related]
9. Protection against anthrax and plague by a combined vaccine in mice and rabbits. Ren J; Dong D; Zhang J; Zhang J; Liu S; Li B; Fu L; Xu J; Yu C; Hou L; Li J; Chen W Vaccine; 2009 Dec; 27(52):7436-41. PubMed ID: 19635609 [TBL] [Abstract][Full Text] [Related]
10. Protection against lethal subcutaneous challenge of virulent Y. pestis strain 141 using an F1-V subunit vaccine. Wang D; Jia N; Li P; Xing L; Wang X Sci China C Life Sci; 2007 Oct; 50(5):600-4. PubMed ID: 17879056 [TBL] [Abstract][Full Text] [Related]
11. Protective immunity in mice achieved with dry powder formulation and alternative delivery of plague F1-V vaccine. Huang J; D'Souza AJ; Alarcon JB; Mikszta JA; Ford BM; Ferriter MS; Evans M; Stewart T; Amemiya K; Ulrich RG; Sullivan VJ Clin Vaccine Immunol; 2009 May; 16(5):719-25. PubMed ID: 19261773 [TBL] [Abstract][Full Text] [Related]
13. Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague. Williamson ED; Stagg AJ; Eley SM; Taylor R; Green M; Jones SM; Titball RW Vaccine; 2007 Jan; 25(6):1142-8. PubMed ID: 17101198 [TBL] [Abstract][Full Text] [Related]
14. Immunisation against plague by transcutaneous and intradermal application of subunit antigens. Eyles JE; Elvin SJ; Westwood A; Lebutt CS; Alpar HO; Somavarapu S; Williamson ED Vaccine; 2004 Oct; 22(31-32):4365-73. PubMed ID: 15474730 [TBL] [Abstract][Full Text] [Related]
16. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague. Arnaboldi PM; Sambir M; D'Arco C; Peters LA; Seegers JF; Mayer L; McCormick AA; Dattwyler RJ Vaccine; 2016 Nov; 34(47):5768-5776. PubMed ID: 27745954 [TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and efficacy of an anthrax/plague DNA fusion vaccine in a mouse model. Albrecht MT; Eyles JE; Baillie LW; Keane-Myers AM FEMS Immunol Med Microbiol; 2012 Aug; 65(3):505-9. PubMed ID: 22515653 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates. Williamson ED; Flick-Smith HC; Waters E; Miller J; Hodgson I; Le Butt CS; Hill J Microb Pathog; 2007 Jan; 42(1):11-21. PubMed ID: 17107769 [TBL] [Abstract][Full Text] [Related]
19. A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague. Yamanaka H; Hoyt T; Yang X; Golden S; Bosio CM; Crist K; Becker T; Maddaloni M; Pascual DW Infect Immun; 2008 Oct; 76(10):4564-73. PubMed ID: 18694965 [TBL] [Abstract][Full Text] [Related]